Cytochrome P450 Retinoic Acid 4-Hydroxylase Inhibitors: Potential Agents for Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|2|3|261-269

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.2, Iss.3, 2002-06, pp. : 261-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytochrome P450 Gene-directed Enzyme Prodrug Therapy (GDEPT) for Cancer

By  

Current Pharmaceutical Design, Vol. 8, Iss. 15, 2002-07 ,pp. : 1405-1416

Bentham Science Publishers

Access to resources Recommend Favorite

Cytochrome P450 4A Fatty Acid Omega Hydroxylases

By  

Current Drug Metabolism, Vol. 2, Iss. 3, 2001-09 ,pp. : 265-281

Bentham Science Publishers

Access to resources Recommend Favorite

The Cytochrome P450 4 (CYP4) Family

By Simpson A.E.C.M.  

General Pharmacology, Vol. 28, Iss. 3, 1997-03 ,pp. : 351-359

Elsevier

Access to resources Recommend Favorite

Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4

By  

Current Drug Metabolism, Vol. 9, Iss. 4, 2008-01 ,pp. : 310-322

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Drugs that Behave as Mechanism-Based Inhibitors of Cytochrome P450 3A4

By  

Current Drug Metabolism, Vol. 5, Iss. 5, 2004-01 ,pp. : 415-442

Bentham Science Publishers

Access to resources Recommend Favorite